Silk Road Medical, Inc

Sümbol: SILK

NASDAQ

18.97

USD

Turuhind täna

-15.0008
P/E suhe
0.1739
PEG suhe
743.14M
MRK Cap
0.00%
DIV tootlus

Silk Road Medical, Inc (SILK) Finantsaruanded

Q: Mis on Silk Road Medical, Inc (SILK) koguvara?

Silk Road Medical, Inc (SILK) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Silk Road Medical, Inc (SILK) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Silk Road Medical, Inc fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018
balance-sheet.row.cash-and-short-term-investments	181.5	213.7	110.2	147.5	90.7	25	33.3
balance-sheet.row.short-term-investments	161.3	158.3	0	78	51.5	0	0
balance-sheet.row.net-receivables	23.6	18	11.8	9.1	8.6	4.5	5.2
balance-sheet.row.inventory	29.9	19.3	17.9	10	10.3	5.7	3.2
balance-sheet.row.other-current-assets	5.9	3.9	3.4	6.8	2.9	1.4	0.3
balance-sheet.row.total-current-assets	240.8	254.9	143.3	173.3	112.5	36.7	42.1
balance-sheet.row.property-plant-equipment-net	14.6	9.4	7.7	2.8	2.7	2.9	0.5
balance-sheet.row.goodwill	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0.1	0.1	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0.1	0.1	0	0	0	0
balance-sheet.row.long-term-investments	9.5	0.2	0.2	0.3	18.2	0	0
balance-sheet.row.tax-assets	0	-0.2	-0.3	0	0	0	0
balance-sheet.row.other-non-current-assets	0.4	5.3	5.6	2.8	4	1.3	0.5
balance-sheet.row.total-non-current-assets	24.5	14.8	13.3	6	24.9	4.2	1
balance-sheet.row.other-assets	0	0	0	0	0	0	0
balance-sheet.row.total-assets	265.3	269.7	156.6	179.3	137.4	40.9	43.1
balance-sheet.row.account-payables	5.7	2.5	2.4	2.6	1.9	1.3	1.5
balance-sheet.row.short-term-debt	1.7	1.8	3.9	0.8	0.8	0	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	75.6	74.6	44.8	48.5	44.9	44.2	27.6
Deferred Revenue Non Current	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	22.8	19.9	19.6	15.9	14	7.6	3.1
balance-sheet.row.total-non-current-liabilities	83.9	81.3	51.3	52.3	48.6	45.3	137
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	7.3	1.8	1.3	0.8	3.7	0	0
balance-sheet.row.total-liab	114.2	105.8	77.4	71.8	65.5	54.1	141.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-399.5	-343.7	-288.7	-238.9	-191.5	-139.1	-101.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	0.1	-0.2	0	0	0	-0.9	-1.3
balance-sheet.row.other-total-stockholders-equity	550.5	507.7	367.9	346.3	263.4	126.8	4.3
balance-sheet.row.total-stockholders-equity	151.2	163.9	79.2	107.5	71.9	-13.2	-98.6
balance-sheet.row.total-liabilities-and-stockholders-equity	265.3	269.7	156.6	179.3	137.4	40.9	43.1
balance-sheet.row.minority-interest	0	0	0	0	0	0	0
balance-sheet.row.total-equity	151.2	163.9	79.2	107.5	71.9	-13.2	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-
Total Investments	170.7	158.3	0.2	78	69.7	0	0
balance-sheet.row.total-debt	84.6	76.4	48.7	48.5	44.9	44.2	27.6
balance-sheet.row.net-debt	64.4	21.1	-61.5	-20.9	5.7	19.2	-5.7

Rahavoogude aruanne

Silk Road Medical, Inc finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018
cash-flows.row.net-income	-55.7	-55	-49.8	-47.4	-52.4	-37.6	-19.4
cash-flows.row.depreciation-and-amortization	3.8	3.2	1.9	1.4	1.3	0.5	0.1
cash-flows.row.deferred-income-tax	-59.8	0	0.7	-2.3	21.2	13.9	-2.5
cash-flows.row.stock-based-compensation	38.9	25	14.6	7.2	3	0.9	0.5
cash-flows.row.change-in-working-capital	-13.9	-6	-6.5	-1.4	-3	-1	-5.9
cash-flows.row.account-receivables	-5.6	-6.2	-2.8	-0.4	-2.2	-1	-4.8
cash-flows.row.inventory	-10.8	-1.4	-5.6	-2.2	-4.7	-2.6	-2.4
cash-flows.row.account-payables	3.1	1	-1.2	0.6	0.6	-0.3	0.7
cash-flows.row.other-working-capital	-0.6	0.6	3	0.6	3.3	2.8	0.6
cash-flows.row.other-non-cash-items	54.8	0.3	0.2	0.3	0.4	1.6	1.8
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-1.5	-5	-4.8	-0.8	-0.5	-2.3	-0.4
cash-flows.row.acquisitions-net	0	157.1	0	8.6	0	0	0
cash-flows.row.purchases-of-investments	-175	-168.2	0	-79.9	-69.4	0	0
cash-flows.row.sales-maturities-of-investments	169.3	11.1	77.4	71.4	0	0	0
cash-flows.row.other-investing-activites	0	-157.1	0	-8.6	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-7.2	-162.1	72.6	-9.4	-70	-2.3	-0.4
cash-flows.row.debt-repayment	0	-49	0	-40	0	0	0
cash-flows.row.common-stock-issued	3.9	114.8	6.9	75.7	111.9	0.7	0.3
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	0	73.9	0	46	1.8	14.8	46.8
cash-flows.row.net-cash-used-provided-by-financing-activities	3.9	139.7	7	81.7	113.8	15.4	47.2
cash-flows.row.effect-of-forex-changes-on-cash	0.2	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-35.1	-55	40.7	30.3	14.2	-8.5	21.5
cash-flows.row.cash-at-end-of-period	20.2	55.5	110.5	69.8	39.5	25.3	33.8
cash-flows.row.cash-at-beginning-of-period	55.4	110.5	69.8	39.5	25.3	33.8	12.4
cash-flows.row.operating-cash-flow	-32	-32.6	-38.9	-42.1	-29.6	-21.7	-25.3
cash-flows.row.capital-expenditure	-1.5	-5	-4.8	-0.8	-0.5	-2.3	-0.4
cash-flows.row.free-cash-flow	-33.5	-37.6	-43.7	-42.9	-30.1	-24	-25.7

Kasumiaruande rida

Silk Road Medical, Inc tulud muutusid võrreldes eelmise perioodiga NaN%. SILK brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018
income-statement-row.row.total-revenue	177.1	138.6	101.5	75.2	63.4	34.6	14.3
income-statement-row.row.cost-of-revenue	50	37.9	25.4	21.3	15.9	10.9	5.1
income-statement-row.row.gross-profit	127.1	100.8	76	53.9	47.4	23.7	9.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.4	-0.2	0	-0.1	-21.1	-12.1	2.9
income-statement-row.row.operating-expenses	186.4	152.8	123.5	96.8	75.5	45.1	27.5
income-statement-row.row.cost-and-expenses	236.4	190.6	148.9	118.1	91.4	56	32.6
income-statement-row.row.interest-income	10	2.5	0.2	1.1	1.7	0.2	0
income-statement-row.row.interest-expense	6.9	5.1	2.5	4.4	5	4.4	3.9
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	3.5	-3	-2.3	-4.5	-24.4	-12.1	2.9
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.4	-0.2	0	-0.1	-21.1	-12.1	2.9
income-statement-row.row.total-operating-expenses	3.5	-3	-2.3	-4.5	-24.4	-12.1	2.9
income-statement-row.row.interest-expense	6.9	5.1	2.5	4.4	5	4.4	3.9
income-statement-row.row.depreciation-and-amortization	3.8	2.3	0.2	1.1	1.7	0.5	0.1
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-59.3	-52	-47.5	-42.9	-28.1	-21.4	-18.4
income-statement-row.row.income-before-tax	-55.7	-55	-49.8	-47.4	-52.4	-37.6	-19.4
income-statement-row.row.income-tax-expense	0	3	0.6	3	3.7	-11.9	6.9
income-statement-row.row.net-income	-55.7	-58	-50.4	-50.4	-56.1	-37.6	-19.4